Literature DB >> 24713658

Hepatic nuclear corepressor 1 regulates cholesterol absorption through a TRβ1-governed pathway.

Inna Astapova, Preeti Ramadoss, Ricardo H Costa-e-Sousa, Felix Ye, Kaila A Holtz, Yingxia Li, Michele W Niepel, David E Cohen, Anthony N Hollenberg.   

Abstract

Transcriptional coregulators are important components of nuclear receptor (NR) signaling machinery and provide additional mechanisms for modulation of NR activity. Expression of a mutated nuclear corepressor 1 (NCoR1) that lacks 2 NR interacting domains (NCoRΔID) in the liver leads to elevated expression of genes regulated by thyroid hormone receptor (TR) and liver X receptor (LXR), both of which control hepatic cholesterol metabolism. Here, we demonstrate that expression of NCoRΔID in mouse liver improves dietary cholesterol tolerance in an LXRα-independent manner. NCoRΔID-associated cholesterol tolerance was primarily due to diminished intestinal cholesterol absorption as the result of changes in the composition and hydrophobicity of the bile salt pool. Alterations of the bile salt pool were mediated by increased expression of genes encoding the bile acid metabolism enzymes CYP27A1 and CYP3A11 as well as canalicular bile salt pump ABCB11. We have determined that these genes are regulated by thyroid hormone and that TRβ1 is recruited to their regulatory regions. Together, these data indicate that interactions between NCoR1 and TR control a specific pathway involved in regulation of cholesterol metabolism and clearance.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24713658      PMCID: PMC4001554          DOI: 10.1172/JCI73419

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  63 in total

1.  Dramatically increased intestinal absorption of cholesterol following hypophysectomy is normalized by thyroid hormone.

Authors:  Cecilia Gälman; Ylva Bonde; Manuela Matasconi; Bo Angelin; Mats Rudling
Journal:  Gastroenterology       Date:  2008-01-17       Impact factor: 22.682

2.  Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia.

Authors:  Paul W Ladenson; Jens D Kristensen; E Chester Ridgway; Anders G Olsson; Bo Carlsson; Irwin Klein; John D Baxter; Bo Angelin
Journal:  N Engl J Med       Date:  2010-03-11       Impact factor: 91.245

3.  Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis.

Authors:  Sushant Bhatnagar; Holly A Damron; F Bradley Hillgartner
Journal:  J Biol Chem       Date:  2009-02-20       Impact factor: 5.157

4.  Regulation of the human cholesterol 7alpha-hydroxylase gene (CYP7A1) by thyroid hormone in transgenic mice.

Authors:  Victor A B Drover; Luis B Agellon
Journal:  Endocrinology       Date:  2003-10-30       Impact factor: 4.736

5.  The nuclear corepressor, NCoR, regulates thyroid hormone action in vivo.

Authors:  Inna Astapova; Larissa J Lee; Crystal Morales; Stefanie Tauber; Martin Bilban; Anthony N Hollenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-03       Impact factor: 11.205

6.  Sexually dimorphic regulation and induction of P450s by the constitutive androstane receptor (CAR).

Authors:  J P Hernandez; L C Mota; W Huang; D D Moore; W S Baldwin
Journal:  Toxicology       Date:  2008-11-11       Impact factor: 4.221

7.  The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans.

Authors:  Anders Berkenstam; Jens Kristensen; Karin Mellström; Bo Carlsson; Johan Malm; Stefan Rehnmark; Neeraj Garg; Carl Magnus Andersson; Mats Rudling; Folke Sjöberg; Bo Angelin; John D Baxter
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-26       Impact factor: 11.205

8.  The liver-selective thyromimetic T-0681 influences reverse cholesterol transport and atherosclerosis development in mice.

Authors:  Ivan Tancevski; Egon Demetz; Philipp Eller; Kristina Duwensee; Julia Hoefer; Christiane Heim; Ursula Stanzl; Andreas Wehinger; Kristina Auer; Regina Karer; Julia Huber; Wilfried Schgoer; Miranda Van Eck; Jonathan Vanhoutte; Catherine Fievet; Frans Stellaard; Mats Rudling; Josef R Patsch; Andreas Ritsch
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.240

9.  LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor.

Authors:  Noam Zelcer; Cynthia Hong; Rima Boyadjian; Peter Tontonoz
Journal:  Science       Date:  2009-06-11       Impact factor: 47.728

10.  Ligand activation of LXR beta reverses atherosclerosis and cellular cholesterol overload in mice lacking LXR alpha and apoE.

Authors:  Michelle N Bradley; Cynthia Hong; Mingyi Chen; Sean B Joseph; Damien C Wilpitz; Xuping Wang; Aldons J Lusis; Allan Collins; Willa A Hseuh; Jon L Collins; Rajendra K Tangirala; Peter Tontonoz
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

View more
  14 in total

1.  Thyroid Hormone and Alcoholic Fatty Liver: The Developmental Input.

Authors:  Arturo Hernandez
Journal:  Alcohol Clin Exp Res       Date:  2019-07-24       Impact factor: 3.455

2.  Fructose and glucose can regulate mammalian target of rapamycin complex 1 and lipogenic gene expression via distinct pathways.

Authors:  Yue Hu; Ivana Semova; Xiaowei Sun; Hong Kang; Satyapal Chahar; Anthony N Hollenberg; David Masson; Matthew D Hirschey; Ji Miao; Sudha B Biddinger
Journal:  J Biol Chem       Date:  2017-12-08       Impact factor: 5.157

3.  NCoR1 and SMRT play unique roles in thyroid hormone action in vivo.

Authors:  Hiroaki Shimizu; Inna Astapova; Felix Ye; Martin Bilban; Ronald N Cohen; Anthony N Hollenberg
Journal:  Mol Cell Biol       Date:  2014-11-24       Impact factor: 4.272

4.  Thyroid and Cardiovascular Disease: Research Agenda for Enhancing Knowledge, Prevention, and Treatment.

Authors:  Anne R Cappola; Akshay S Desai; Marco Medici; Lawton S Cooper; Debra Egan; George Sopko; Glenn I Fishman; Steven Goldman; David S Cooper; Samia Mora; Peter J Kudenchuk; Anthony N Hollenberg; Cheryl L McDonald; Paul W Ladenson
Journal:  Thyroid       Date:  2019-05-13       Impact factor: 6.568

5.  Thyroid and Cardiovascular Disease Research Agenda for Enhancing Knowledge, Prevention, and Treatment.

Authors:  Anne R Cappola; Akshay S Desai; Marco Medici; Lawton S Cooper; Debra Egan; George Sopko; Glenn I Fishman; Steven Goldman; David S Cooper; Samia Mora; Peter J Kudenchuk; Anthony N Hollenberg; Cheryl L McDonald; Paul W Ladenson
Journal:  Circulation       Date:  2019-05-13       Impact factor: 29.690

6.  Thyroid hormone signaling promotes hepatic lipogenesis through the transcription factor ChREBP.

Authors:  Arturo Mendoza; Catherine Tang; Jinyoung Choi; Mariana Acuña; Maya Logan; Adriana G Martin; Lujain Al-Sowaimel; Bhavna N Desai; Danielle E Tenen; Christopher Jacobs; Anna Lyubetskaya; Yulong Fu; Hong Liu; Linus Tsai; David E Cohen; Douglas Forrest; Andrew A Wilson; Anthony N Hollenberg
Journal:  Sci Signal       Date:  2021-11-16       Impact factor: 8.192

Review 7.  Re-adopting classical nuclear receptors by cholesterol metabolites.

Authors:  Michihisa Umetani
Journal:  J Steroid Biochem Mol Biol       Date:  2015-11-10       Impact factor: 4.292

Review 8.  New avenues for regulation of lipid metabolism by thyroid hormones and analogs.

Authors:  Rosalba Senese; Pasquale Lasala; Cristina Leanza; Pieter de Lange
Journal:  Front Physiol       Date:  2014-12-05       Impact factor: 4.566

9.  Nuclear corepressor SMRT is a strong regulator of body weight independently of its ability to regulate thyroid hormone action.

Authors:  Hiroaki Shimizu; Yu Lu; Kristen R Vella; Federico Damilano; Inna Astapova; Izuki Amano; Megan Ritter; Molly R Gallop; Anthony N Rosenzweig; Ronald N Cohen; Anthony N Hollenberg
Journal:  PLoS One       Date:  2019-08-12       Impact factor: 3.240

10.  The Intrinsic Activity of Thyroxine Is Critical for Survival and Growth and Regulates Gene Expression in Neonatal Liver.

Authors:  Valerie Anne Galton; Maria Elena Martinez; Julie A Dragon; Donald L St Germain; Arturo Hernandez
Journal:  Thyroid       Date:  2020-09-16       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.